The Food and Drug Administration (FDA) on Thursday approved a higher dose of the Wegovy weight loss drug. The manufacturer, Novo Nordisk, increased the semaglutide injection by 4.8 mg to total 7.2 mg. The company says the higher dosage is recommended for those who taken the lower dose already for at least four weeks… » …
FDA approves higher dose of Wegovy
Subscribe Today
GET EXCLUSIVE FULL ACCESS TO PREMIUM CONTENT
SUPPORT NONPROFIT JOURNALISM
EXPERT ANALYSIS OF AND EMERGING TRENDS IN CHILD WELFARE AND JUVENILE JUSTICE
TOPICAL VIDEO WEBINARS
Get unlimited access to our EXCLUSIVE Content and our archive of subscriber stories.